Market Insights Health OTC Pharmaceuticals

Hand Sanitizer - EU-27

EU-27

In the EU-4.56%, the revenue generated in the Hand Sanitizer market market is projected to reach US$0.48bn in 2024.
It is anticipated that the market will experience an annual growth rate of 4.56% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, with an estimated amount of US$643.50m in 2024.
Taking into account the total population, each person in the EU-4.56% is expected to generate revenues of US$1.08 in 2024.
In Germany, the hand sanitizer market is experiencing strong growth due to increased demand from consumers concerned about hygiene amidst the COVID-19 pandemic.

Key regions: Australia, Germany, United States, China, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Hand Sanitizer market in EU-27 is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the EU-27 have shown a growing preference for hand sanitizers in recent years. This can be attributed to increasing awareness about the importance of hand hygiene in preventing the spread of diseases, including the recent COVID-19 pandemic. The convenience and effectiveness of hand sanitizers in killing germs quickly and easily have made them a popular choice among consumers.

Trends in the market: One of the key trends in the Hand Sanitizer market in EU-27 is the shift towards natural and organic products. Consumers are becoming more conscious about the ingredients used in personal care products and are seeking products that are free from harmful chemicals. As a result, there is a growing demand for hand sanitizers that are made from natural and organic ingredients.Another trend in the market is the increasing availability of hand sanitizers in various formats and packaging options. Manufacturers are introducing innovative packaging designs such as pocket-sized bottles, sprays, and wipes to cater to the diverse needs and preferences of consumers. This has contributed to the widespread adoption of hand sanitizers in different settings, including homes, offices, schools, and public spaces.

Local special circumstances: The Hand Sanitizer market in EU-27 is influenced by local regulations and guidelines regarding hand hygiene. The European Union has implemented strict regulations for the manufacturing and labeling of hand sanitizers to ensure their safety and effectiveness. This has led to the emergence of a highly regulated market, with manufacturers required to meet specific standards and obtain necessary certifications.Additionally, the COVID-19 pandemic has had a significant impact on the Hand Sanitizer market in EU-27. The increased emphasis on hand hygiene and the implementation of hygiene protocols in various sectors, including healthcare, hospitality, and retail, have led to a surge in demand for hand sanitizers. This has created new opportunities for manufacturers and suppliers in the market.

Underlying macroeconomic factors: The Hand Sanitizer market in EU-27 is also influenced by macroeconomic factors such as population growth, urbanization, and disposable income levels. The region has a large population, and the growing urbanization has resulted in increased awareness about personal hygiene and health. Rising disposable income levels have also enabled consumers to spend more on personal care products, including hand sanitizers.Moreover, the increasing prevalence of infectious diseases and the need for effective infection control measures have further fueled the demand for hand sanitizers. The EU-27 has witnessed outbreaks of various diseases in recent years, such as influenza and norovirus, which have highlighted the importance of hand hygiene in preventing the spread of infections.In conclusion, the Hand Sanitizer market in EU-27 is experiencing significant growth due to customer preferences for convenient and effective hand hygiene solutions, trends towards natural and organic products, local regulations and guidelines, and underlying macroeconomic factors such as population growth and increasing awareness about health and hygiene.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.